A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
R.WozniakD
Vitamin B12, combined with Methionine, Inositol, and Choline, creates a synergistic effect that not only aids in weight management but also supports overall cellular health
Also, that adipose tissue, fat tissue, produces a lot of hormones that- Craig: It does
Each batch is produced under controlled conditions and undergoes quality checks to confirm it meets our internal standards before being released
The Gauntlet: Peptide Stability and Gastric Transit To truly appreciate the empty stomach protocol, you have to understand the formidable challenge a peptide faces in the digestive system
